BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38116002)

  • 21. Eutopic endometrium from patients with endometriosis modulates the expression of CD36 and SIRP-α in peritoneal macrophages.
    Xie Q; He H; Wu YH; Zou LJ; She XL; Xia XM; Wu XQ
    J Obstet Gynaecol Res; 2019 May; 45(5):1045-1057. PubMed ID: 30843336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting SIRP-α protects from type 2-driven allergic airway inflammation.
    Raymond M; Van VQ; Rubio M; Welzenbach K; Sarfati M
    Eur J Immunol; 2010 Dec; 40(12):3510-8. PubMed ID: 21108471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Signal regulatory proteins in the immune system.
    van Beek EM; Cochrane F; Barclay AN; van den Berg TK
    J Immunol; 2005 Dec; 175(12):7781-7. PubMed ID: 16339510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer.
    Matlung HL; Szilagyi K; Barclay NA; van den Berg TK
    Immunol Rev; 2017 Mar; 276(1):145-164. PubMed ID: 28258703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity.
    Kuo TC; Chen A; Harrabi O; Sockolosky JT; Zhang A; Sangalang E; Doyle LV; Kauder SE; Fontaine D; Bollini S; Han B; Fu YX; Sim J; Pons J; Wan HI
    J Hematol Oncol; 2020 Nov; 13(1):160. PubMed ID: 33256806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD47/SIRPα pathway mediates cancer immune escape and immunotherapy.
    Jia X; Yan B; Tian X; Liu Q; Jin J; Shi J; Hou Y
    Int J Biol Sci; 2021; 17(13):3281-3287. PubMed ID: 34512146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The interaction between signal regulatory protein alpha (SIRPα) and CD47: structure, function, and therapeutic target.
    Barclay AN; Van den Berg TK
    Annu Rev Immunol; 2014; 32():25-50. PubMed ID: 24215318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SIRP-alpha-CD47 system functions as an intercellular signal in the renal glomerulus.
    Kurihara H; Harita Y; Ichimura K; Hattori S; Sakai T
    Am J Physiol Renal Physiol; 2010 Sep; 299(3):F517-27. PubMed ID: 20554646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SIRP Alpha Protein Downregulates in Human Astrocytoma: Presumptive Involvement of Hsa-miR-520d-5p and Hsa-miR-520d-3p.
    Deshpande RP; Chandra Sekhar YBVK; Panigrahi M; Babu PP
    Mol Neurobiol; 2017 Dec; 54(10):8162-8169. PubMed ID: 27900675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective control of SIRP-alpha-positive airway dendritic cell trafficking through CD47 is critical for the development of T(H)2-mediated allergic inflammation.
    Raymond M; Rubio M; Fortin G; Shalaby KH; Hammad H; Lambrecht BN; Sarfati M
    J Allergy Clin Immunol; 2009 Dec; 124(6):1333-42.e1. PubMed ID: 19748659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deficiency in SIRP-α cytoplasmic recruitment confers protection from acute kidney injury.
    Ghimire K; Chiba T; Minhas N; Meijles DN; Lu B; O'Connell P; Rogers NM
    FASEB J; 2019 Oct; 33(10):11528-11540. PubMed ID: 31370677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Soluble extracellular domains of human SIRPα and CD47 expressed in Escherichia coli enhances the phagocytosis of leukemia cells by macrophages in vitro.
    Lin Y; Yan XQ; Yang F; Yang XW; Jiang X; Zhao XC; Zhu BK; Liu L; Qin HY; Liang YM; Han H
    Protein Expr Purif; 2012 Sep; 85(1):109-16. PubMed ID: 22813925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer immunotherapy targeting the CD47/SIRPα axis.
    Weiskopf K
    Eur J Cancer; 2017 May; 76():100-109. PubMed ID: 28286286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy.
    Schürch CM; Roelli MA; Forster S; Wasmer MH; Brühl F; Maire RS; Di Pancrazio S; Ruepp MD; Giger R; Perren A; Schmitt AM; Krebs P; Charles RP; Dettmer MS
    Thyroid; 2019 Jul; 29(7):979-992. PubMed ID: 30938231
    [No Abstract]   [Full Text] [Related]  

  • 35. Expression levels of CD47, CD35, CD55, and CD59 on red blood cells and signal-regulatory protein-alpha,beta on monocytes from patients with warm autoimmune hemolytic anemia.
    Barros MM; Yamamoto M; Figueiredo MS; Cançado R; Kimura EY; Langhi DM; Chiattone CS; Bordin JO
    Transfusion; 2009 Jan; 49(1):154-60. PubMed ID: 18954403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Signal regulatory protein (SIRPalpha), a cellular ligand for CD47, regulates neutrophil transmigration.
    Liu Y; Bühring HJ; Zen K; Burst SL; Schnell FJ; Williams IR; Parkos CA
    J Biol Chem; 2002 Mar; 277(12):10028-36. PubMed ID: 11792697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional CD47/signal regulatory protein alpha (SIRP(alpha)) interaction is required for optimal human T- and natural killer- (NK) cell homeostasis in vivo.
    Legrand N; Huntington ND; Nagasawa M; Bakker AQ; Schotte R; Strick-Marchand H; de Geus SJ; Pouw SM; Böhne M; Voordouw A; Weijer K; Di Santo JP; Spits H
    Proc Natl Acad Sci U S A; 2011 Aug; 108(32):13224-9. PubMed ID: 21788504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engineering macrophages to phagocytose cancer cells by blocking the CD47/SIRPɑ axis.
    Yang H; Shao R; Huang H; Wang X; Rong Z; Lin Y
    Cancer Med; 2019 Aug; 8(9):4245-4253. PubMed ID: 31183992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of AO-176, a Next-Generation Humanized Anti-CD47 Antibody with Novel Anticancer Properties and Negligible Red Blood Cell Binding.
    Puro RJ; Bouchlaka MN; Hiebsch RR; Capoccia BJ; Donio MJ; Manning PT; Frazier WA; Karr RW; Pereira DS
    Mol Cancer Ther; 2020 Mar; 19(3):835-846. PubMed ID: 31879362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic and Epigenetic Regulation of the Innate Immune Response to Gout.
    de Lima JD; de Paula AGP; Yuasa BS; de Souza Smanioto CC; da Cruz Silva MC; Dos Santos PI; Prado KB; Winter Boldt AB; Braga TT
    Immunol Invest; 2023 Apr; 52(3):364-397. PubMed ID: 36745138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.